QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 axovant-gene-therapies-announces-name-change-to-sio-gene-therapies

Rebranding to Sio Gene Therapies to reflect an independent company with a scientific strategy focused on disease-modifying an...

 axovant-gene-therapies-announces-fda-clearance-of-ind-for-axo-aav-gm2-gene-therapy-in-tay-sachs-and-sandhoff-diseases

AXO-AAV-GM2 is the first investigational gene therapy to receive IND clearance in Tay-Sachs and Sandhoff diseases Represen...

 68-biggest-movers-from-yesterday
68 Biggest Movers From Yesterday
11/09/2020 10:18:42

Gainers

 76-biggest-movers-from-friday
76 Biggest Movers From Friday
11/02/2020 09:20:11

Gainers Marine Petroleum Trust (NASDAQ: MARPS) shares climbed 35.4% to close at $3.33 on Friday.

Core News & Articles

Toward the end of trading Friday, the Dow traded down 1.45% to 26,272.64 while the NASDAQ fell 2.93% to 10,857.97. The S&P ...

Core News & Articles

Gainers Marine Petroleum Trust (NASDAQ: MARPS) shares jumped 121.5% to $5.45.

Core News & Articles

Midway through trading Friday, the Dow traded down 1.31% to 26,310.67 while the NASDAQ fell 2.78% to 10,874.14. The S&P als...

Core News & Articles

Following the market opening Friday, the Dow traded down 0.61% to 26,496.09 while the NASDAQ fell 1.92% to 10,970.56. The S&am...

 the-daily-biotech-pulse-novavax-vaccine-data-axovant-flags-delay-in-parkinsons-study-2-biotechs-make-wall-street-debuts

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 36-stocks-moving-in-fridays-pre-market-session

Gainers Air Industries Group (NASDAQ: AIRI) rose 53% to $1.58 in pre-market trading after the company Reported Thursday that...

Core News & Articles

Gainers Equillium (NASDAQ:EQ) shares increased by 16.5% to $6.99 during Thursday's after-market session. Equillium's t...

 axovant-gene-therapies-to-present-axo-lenti-pd-program-update-during-virtual-parkinsons-disease-rd-day-on-october-30-2020

Patient-level data in cohort 2 of SUNRISE-PD study demonstrates consistent, clinically meaningful outcomes and evidence of do...

 the-week-ahead-in-biotech-kala-fda-decision-merck--pfizer-earnings-vaccine-updates-and-ipos

Biotech stocks posted weekly declines in the week ended Oct. 23, pressured by the broader market decline amid mixed earnings re...

Core News & Articles

Today's 5 Stock Ideas:  Apple (AAPL) - Will host an event Tuesday to unveil the new iPhone. The event will begin at 1 p....

 the-daily-biotech-pulse-jj-pauses-coronavirus-vaccine-studies-voyagers-huntingtons-disease-study-placed-on-hold-altimmune-vaccine-data

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitti...

 axovant-gene-therapies-receives-rare-pediatric-disease-designation-for-axo-aav-gm2-for-tay-sachs-and-sandhoff-disease

Axovant Gene Therapies Ltd. (NASDAQ:AXGT), a clinical-stage company developing innovative gene therapies for neurological disea...

 the-daily-biotech-pulse-fda-panel-review-for-alkermes-axovant-gets-rare-pediatric-disease-designation-2-ipos

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitti...

 axovant-gene-therapies-receives-rare-pediatric-disease-designation-for-axo-aav-gm1-for-gm1-gangliosidosis

NEW YORK, Oct. 09, 2020 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (NASDAQ:AXGT), a clinical-stage company developing inno...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION